Jikui Guan

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Clinical and genetic characteristics of X-linked intellectual disability associated with HUWE1 gene variants

Clinical and genetic characteristics of X-linked intellectual disability associated with HUWE1 gene variants

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: November 13, 2025

Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-report.

Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-report.

Journal: NPJ precision oncology
Published: July 10, 2025

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 28, 2023

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib.

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib.

Journal: Frontiers in oncology
Published: August 22, 2023

IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway.

IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway.

Journal: Cancers
Published: June 17, 2023

Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.

Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.

Journal: Frontiers in immunology
Published: April 02, 2023

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.

Journal: JCO precision oncology
Published: January 27, 2022

Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia

Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: January 06, 2022

Chromosome Imbalances in Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future.

Chromosome Imbalances in Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future.

Journal: Cancers
Published: November 01, 2021

Mapping the Phospho-dependent ALK Interactome to Identify Novel Components in ALK Signaling.

Mapping the Phospho-dependent ALK Interactome to Identify Novel Components in ALK Signaling.

Journal: Journal of molecular biology
Published: July 14, 2021

BioID-Screening Identifies PEAK1 and SHP2 as Components of the ALK Proximitome in Neuroblastoma Cells.

BioID-Screening Identifies PEAK1 and SHP2 as Components of the ALK Proximitome in Neuroblastoma Cells.

Journal: Journal of molecular biology
Published: April 14, 2021

Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells.

Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells.

Journal: Cancers
Published: January 31, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026